Russia's leading COVID-19 vaccine producer says Sputnik V is more than 95% effective and will be cheaper than other candidates. A second set of interim data has been released for the vaccine, which is in phase three of clinical trials, but has already been approved by regulators. Julia Chapman has more.
IN: According to...
OUT: SOC
DUR: 0:49
http://www.fsnradionews.com/feeds/1124SputnikV-jc.mp3
IN: According to...
OUT: SOC
DUR: 0:49
http://www.fsnradionews.com/feeds/1124SputnikV-jc.mp3